Company: KVACU
Filing Date: 2025-03-07
Form Type: 10-K
Source: 0001213900-25-021314
Chunk: 121

Company: Keen Vision Acquisition Corp.
Filing Date: 2025-03-07
Form: 10-K
Item: Item 1A
Chunk 121
---
 conferences organizer, Gordon Research Conferences (member of
the Board of Trustees since May 2016), the Asian Fund for Cancer Research Limited (director since July 2011), Hong Kong

Biotechnology Organization
(HKBIO) (founder and chairman since September 2009), Hong Kong DNA Chips Ltd (director since April 2007), and clinical diagnostic firm
Hai Kang Life Corp. Ltd.’s subsidiary DNA-Tech Ltd (director since February 2002).

30

His past directorships of
corporate and academic organizations include the Chinese Neuroscience Society (CNS) (vice director from October 2015 to October 2019),
Hong Kong Science and Technology Parks Limited (HKSTP) (director from July 2011 to June 2017), the Beijing Society for Neuroscience (BJSN)
(director from January 2008 to December 2013), and the key neuroscience laboratory designated by the Chinese Ministry of Education and
Ministry of Health; the Neuroscience Research Institute of Peking University (vice director from December 2006 to December 2018).

Concurrently to his current
role at Peking University, from September 2006 to December 2017, Prof. Yu was a professor at the Peking University Infectious Disease
Research Center. Prior to that, from February 1994 to December 2001, Prof. Yu was a lecturer and assistant professor at the Hong Kong
University of Science and Technology (HKT). From February 1994 to August 1996, he was also a visiting associate professor at Stanford
University, and a guest professor at the Peking University Health Science Center (formerly known as Beijing Medical University) from January
1994 to December 2000. From October 1989 to October 1994, Prof. Yu was a research associate and later senior research associate at Stanford
University’s Department of Pathology. Prior to this, from July 1984 to September 1989, he was an assistant academic researcher at
the University of California, San Francisco.

Prof. Yu earned his Bachelor
of Science, his Master of Science, and his Doctor of Philosophy degrees from the University of Saskatchewan.

We believe Prof. Yu is well-qualified
to serve as a member of our board of directors given his experience, industry expertise, and network.

Director Independence

Nasdaq requires that a majority
of our board must be composed of “Independent Directors.” Currently, Mr. Peter Ding, Mr. William Chu,